1928 Institute

Last updated

The 1928 Institute, formerly India League, is a think tank active in the United Kingdom.

History

The think tank was co-founded by two academics at the University of Oxford in 2020, [1] [2] [3] "to continue the work of the original India League", itself founded in 1928. [4] [5] Initially using the India League name, the think tank rebranded itself the 1928 Institute in October 2020. [3] [6] [7] The 1928 Institute has run an online survey of British Indians, collecting socioeconomic data as well as information on political opinions, media representation of the community, religious identity, experience of racism and domestic violence, and the COVID-19 pandemic. [6] In January 2021, the Institute announced that its research showed that 56 per cent of British Indians would take a COVID-19 vaccine, compared to 79 per cent of the overall population. [2] One of the Institute's co-founders stated that "It seems that the Indian/south Asian population in general have been really falling prey to [misinformation] through things like WhatsApp forwards and fake news. And a lot of it seems to be directed at fertility, which is, I think, very interesting because there is no evidence to suggest that the vaccine causes fertility issues". [1]

Writing for Byline Times, Amrit Wilson wrote that "while the India League saw the struggle in India as part of a larger struggle against imperialism and racism – and included such socialists and anti-imperialists as Harold Laski, Bertrand Russell and Fenner Brockway – the 1928 Institute's list of 'notable members' includes a corporate billionaire who admires [Narendra] Modi. Even the Prince of Udaipur, scion of one of India's most wealthy oppressor caste Rajput dynasties, is on board". The organisation responded by stating that it had "diverse members with no influence over the organisation". [8]

As of April 2022, the 1928 Institute describes itself as "a not-for-profit University of Oxford spin-out" with a mission to "research and represent British Indians", "provide analysis on the emerging events in the Indian Sub-continent and within its diaspora" and "be a platform for dialogue for the diaspora and to disrupt 'echo-chambers'". [9]

The Institute acts as the secretariat for the India (Trade and Investment) All Party Parliamentary Group, which was created in July 2022. [10]

Related Research Articles

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Amrit Kaur</span> Indian politician (1889–1964)

Rajkumari Dame Bibiji Amrit Kaur DStJ was an Indian activist and politician. Following her long-lasting association with the Indian independence movement, she was appointed the first Health Minister of India in 1947 and remained in office until 1957. She also held the charge of Sports Minister and Urban Development Minister and was instrumental in setting up the National Institute of Sports, Patiala. During her tenure, Kaur ushered in several healthcare reforms in India and is widely remembered for her contributions to the sector and her advocacy of women's rights. Kaur was also a member of the Constituent Assembly of India, the body that framed the Constitution of India.

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.

<span class="mw-page-title-main">British Indians</span> British people of Indian descent

British Indians are citizens of the United Kingdom (UK) whose ancestral roots are from India. This includes people born in the UK who are of Indian origin as well as Indians who have migrated to the UK. Currently, the British Indian population exceeds 1.8 million people in the UK, making them the single largest visible ethnic minority population in the country. They make up the largest subgroup of British Asians and are one of the largest Indian communities in the Indian diaspora, mainly due to the Indian–British relations. The British Indian community is the sixth largest in the Indian diaspora, behind the Indian communities in the United States, Saudi Arabia, the United Arab Emirates, Malaysia and Nepal. The majority of British Indians are of Punjabi, Gujarati, Bengali and Malayali descent, with smaller Tamil, Telugu, Konkani, and Marathi communities.

<span class="mw-page-title-main">Sunetra Gupta</span> British novelist and epidemiologist

Sunetra Gupta is an Indian-born British infectious disease epidemiologist and a professor of theoretical epidemiology at the Department of Zoology, University of Oxford. She has performed research on the transmission dynamics of various infectious diseases, including malaria, influenza and COVID-19, and has received the Scientific Medal of the Zoological Society of London and the Rosalind Franklin Award of the Royal Society. She is a member of the scientific advisory board of Collateral Global, an organisation which examines the global impact of COVID-19 restrictions.

<span class="mw-page-title-main">Neil O'Brien</span> British Conservative politician

Neil John O'Brien is a British politician who was appointed Parliamentary Under-Secretary of State for Primary Care and Public Health in September 2022. He was elected Member of Parliament (MP) for Harborough in 2017. A member of the Conservative Party, he was previously a special adviser to Chancellor of the Exchequer George Osborne from 2012 to 2016 and Theresa May during her tenure as Prime Minister.

<span class="mw-page-title-main">Cyrus S. Poonawalla</span> Indian billionaire businessman

Cyrus S. Poonawalla is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world and Poonawalla Fincorp a leading NBFC in India. In 2022, he is ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. He is ranked number 1 on the Hurun Global Healthcare Rich List 2022.

<span class="mw-page-title-main">Claire Coutinho</span> British politician (born 1985)

Claire Coryl Julia Coutinho is a British politician who has served as Secretary of State for Energy Security and Net Zero since August 2023. She previously served as Parliamentary Under-Secretary of State for Children, Families and Wellbeing from October 2022 to August 2023 and Parliamentary Under Secretary of State for Disabled People from September to October 2022. A member of the Conservative Party, she has been the Member of Parliament (MP) for East Surrey since the 2019 general election.

<span class="mw-page-title-main">COVID-19 pandemic in India</span> Ongoing COVID-19 viral pandemic in India

The COVID-19 pandemic in India is a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. As of 2 October 2023, according to Indian government figures, India has the second-highest number of confirmed cases in the world with 44,998,525 reported cases of COVID-19 infection and the third-highest number of COVID-19 deaths at 532,031 deaths. In October 2021, the World Health Organization estimated 4.7 million excess deaths, both directly and indirectly related to COVID-19 to have taken place in India.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Telangana. The first case was recorded in this region on 2 March from a man who had travel history with the UAE.

<span class="mw-page-title-main">Oxford–AstraZeneca COVID-19 vaccine</span> Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose, and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant, and 61% against the Delta variant.

<span class="mw-page-title-main">Sputnik V COVID-19 vaccine</span> Russian vaccine against COVID-19

Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.

<span class="mw-page-title-main">Vaccine Taskforce</span> Non-departmental body coordinating efforts to introduce a COVID-19 vaccine

The Vaccine Taskforce in the United Kingdom of Great Britain and Northern Ireland was set up in April 2020 by the Second Johnson ministry, in collaboration with Chief Scientific Advisor Patrick Vallance and Chief Medical Officer Professor Chris Whitty, in order to facilitate the path towards the introduction of a COVID-19 vaccine in the UK and its global distribution. The taskforce coordinated the research efforts of government with industry, academics and funding agencies in order to expedite vaccine development and deployment.

<span class="mw-page-title-main">COVAX</span> Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.

<span class="mw-page-title-main">Covaxin</span> Vaccine against COVID-19

Covaxin is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.

<span class="mw-page-title-main">COVID-19 vaccination in India</span> Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in Albania</span>

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

<span class="mw-page-title-main">Vaccine Maitri</span> Vaccination initiative by the Indian government

Vaccine Maitri is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines from 20 January 2021. As of 21 February 2022, India had delivered around 16.29 crore doses of vaccines to 96 countries. Of these, 1.43 crore doses were gifted to 98 countries by the Government of India. The remaining 10.71 crore were supplied by the vaccine producers under its commercial and 4.15 crore were supplied by COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. The Health Minister of India, Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.

The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. During the first week, 39,599 doses were applied to health professionals.

References

  1. 1 2 Giordano, Chiara (2021). "Just over half of British Indians would get Covid vaccine, survey shows". The Independent .
  2. 1 2 "Just over half of British Indians would take COVID vaccine". University of Oxford. 2021.
  3. 1 2 Pearce, Vanessa (2021). "Indian activists who helped change the face of modern Britain". BBC .
  4. ↑ "Our Story". 1928 Institute. Archived from the original on 18 April 2021. Retrieved 11 December 2021.
  5. ↑ Bhardwaj, Naina (21 February 2021). "Haunted by unfounded fears for their fertility, British Indians are more likely to resist getting COVID-19 vaccine". Business Insider. Retrieved 20 December 2021.
  6. 1 2 Sherwood, Harriet (2020). "From resisting the Raj to helping with Covid: India League reborn for the 21st century". The Guardian .
  7. ↑ @1928institute (7 October 2020). "ANNOUNCEMENT: From today we are rebranding and will operate under the name as voted by you: the 1928 Institute. The #BritishIndianCensus will be continued by the 1928 Institute, under the same leadership which initiated the study. Watch this space and DM us your thoughts" (Tweet). Retrieved 15 December 2021– via Twitter.
  8. ↑ Wilson, Amrit (9 December 2021). "The New Strategies of Hindu Supremacists in Britain". Byline Times. Retrieved 11 December 2021.
  9. ↑ "Our Mission". 1928 Institute. Retrieved 20 April 2022.
  10. ↑ "New UK parliamentary panel to promote trade, investment ties with India". The Economic Times. 27 July 2022. Retrieved 30 March 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.